Skip to content

The verification of safety and efficacy of ovarian tissue and oocyte cryopreservation for child patients.

The verification of safety and efficacy of ovarian tissue and oocyte cryopreservation for child patients. - The verification of safety and efficacy of ovarian tissue and oocyte cryopreservation for child patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040576
Enrollment
50
Registered
2020-05-30
Start date
2015-11-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia, Lymphoma, rhabdomyosarcoma, Immuno deficiency, CAEBV, hematological disease, auto immune disease, collagen disease

Interventions

None listed

Sponsors

St. Marianna University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The consalt and permission from doctor for mrimary disease, long term survive is expected, the high risk of ovarian dysfunction due to therapy for primary disease, operable condition

Exclusion criteria

Exclusion criteria: No consult and permission from primary doctor, long term survival is not expected, no gonadal risk, very poor general condition

Design outcomes

Primary

MeasureTime frame
safety of surgery(operation time, blood loss, complication),the numbers of ovarian cortex, the numbers of retrieved oocyte

Secondary

MeasureTime frame
The existance of minimal residual disease

Countries

Japan

Contacts

Public ContactSEIDO TAKAE

St. Marianna University School of Medicine Department of Obstetrics and Gynecology

s2takae@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026